GLP 1 Receptor Agonist Market to Reach USD 16.2 Billion by 2032, Driven by Rising Diabetes Prevalence
The global GLP 1 Receptor Agonist Market is witnessing substantial growth due to the increasing prevalence of type 2 diabetes and obesity worldwide. According to Market Intelo, the market was valued at USD 7.8 billion in 2023 and is projected to reach USD 16.2 billion by 2032, growing at a CAGR of 8.2% during the forecast period (2024–2032).
Read Full Research Study: https://marketintelo.com/repor....t/glp-1-receptor-ago